English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Mar 11, 2026

Roche invests $480 million to expand clinical trial capacity in South Korea
+ Pharmaceuticals
Patient Daily | Mar 11, 2026

FDA partially pauses PepGen's phase 2 trial for myotonic dystrophy
+ Pharmaceuticals
Patient Daily | Mar 11, 2026

FDA official seeks hire amid controversy over antidepressant warnings
+ Pharmaceuticals
Patient Daily | Mar 11, 2026

Alnylam partners with Tenaya Therapeutics on genetic heart disease research
+ Pharmaceuticals
Patient Daily | Mar 11, 2026

Analysts say psychedelics unlikely to dominate depression treatment market
+ Pharmaceuticals
Patient Daily | Mar 11, 2026

UniQure weighs next steps after FDA requests new phase 3 trial for Huntington's gene therapy
+ Pharmaceuticals
Patient Daily | Mar 11, 2026

Targeted mRNA restores fertility in genetically infertile male mice
+ Pharmaceuticals
Patient Daily | Mar 11, 2026

Study links impaired tanycyte function to tau buildup in Alzheimer’s disease

Trending
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation
+ Pharmaceuticals
Patient Daily | Aug 7, 2026

Researchers develop computer model linking brain chemistry to neural activity patterns